Biotechnology stocks
1,362 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bavarian Nordic A/SCPSE: BAVA | $2.81B | Dkr247.40 | +0.98% |
| Celcuity Inc.NasdaqCM: CELC | $2.77B | $56.58 | -16.72% |
| Nurix Therapeutics, Inc.NasdaqGM: NRIX | $2.67B | $24.42 | +9.26% |
| Yili Chuanning Biotechnology Co.,Ltd.SZSE: 301301 | $2.64B | CN¥7.90 | -3.89% |
| Xiamen Amoytop Biotech Co., Ltd.SHSE: 688278 | $2.61B | CN¥43.77 | -3.10% |
| Zai Lab LimitedNasdaqGM: ZLAB | $2.60B | $23.19 | -7.20% |
| BioArctic AB (publ)OM: BIOA B | $2.57B | Skr287.40 | -2.71% |
| Viridian Therapeutics, Inc.NasdaqCM: VRDN | $2.53B | $22.37 | -1.97% |
| Acrobiosystems Co.,Ltd.SZSE: 301080 | $2.46B | CN¥97.97 | -19.83% |
| Beam Therapeutics Inc.NasdaqGS: BEAM | $2.40B | $24.05 | -2.08% |
| ADMA Biologics, Inc.NasdaqGM: ADMA | $2.39B | $10.68 | -2.47% |
| NewAmsterdam Pharma Company N.V.NasdaqGM: NAMS | $2.37B | $19.83 | -8.09% |
| Arcus Biosciences, Inc.NYSE: RCUS | $2.36B | $18.54 | -4.24% |
| SELLAS Life Sciences Group, Inc.NasdaqCM: SLS | $2.33B | $11.54 | +1.67% |
| Zealand Pharma A/SCPSE: ZEAL | $2.31B | Dkr226.00 | -2.33% |
| Celldex Therapeutics, Inc.NasdaqCM: CLDX | $2.30B | $29.25 | +0.97% |
| Precigen, Inc.NasdaqGS: PGEN | $2.29B | $6.39 | -18.25% |
| Sinocelltech Group LimitedSHSE: 688520 | $2.28B | CN¥32.46 | -10.38% |
| BGI Genomics Co., Ltd.SZSE: 300676 | $2.26B | CN¥39.43 | -13.28% |
| Aurinia Pharmaceuticals Inc.NasdaqGM: AUPH | $2.24B | $16.86 | -2.71% |
| Recursion Pharmaceuticals, Inc.NasdaqGS: RXRX | $2.21B | $3.70 | +3.35% |
| Agios Pharmaceuticals, Inc.NasdaqGS: AGIO | $2.21B | $37.00 | -0.51% |
| Bonesupport Holding AB (publ)OM: BONEX | $2.19B | Skr332.60 | +4.00% |
| Disc Medicine, Inc.NasdaqGM: IRON | $2.18B | $56.84 | -8.41% |
| PharmaResearch Co., Ltd.KOSDAQ: A214450 | $2.17B | ₩278,000.00 | -8.10% |
| SK bioscience Co.,Ltd.KOSE: A302440 | $2.12B | ₩36,300.00 | -1.22% |
| Sino Biological,Inc.SZSE: 301047 | $2.10B | CN¥115.62 | -21.41% |
| Biohaven Ltd.NYSE: BHVN | $2.10B | $13.88 | -5.51% |
| Shenzhen Kangtai Biological Products Co., Ltd.SZSE: 300601 | $2.07B | CN¥12.43 | -7.51% |
| Vericel CorporationNasdaqGM: VCEL | $2.05B | $40.13 | +0.07% |
| Genus plcLSE: GNS | $2.03B | £22.94 | +2.41% |
| Lakefront Biotherapeutics NVENXTAM: LKFT | $2.02B | €28.14 | +1.88% |
| Anhui Anke Biotechnology (Group) Co., Ltd.SZSE: 300009 | $2.01B | CN¥8.04 | +2.16% |
| Vera Therapeutics, Inc.NasdaqGM: VERA | $2.01B | $27.88 | -6.69% |
| Zymeworks Inc.NasdaqGS: ZYME | $2.00B | $28.22 | -0.77% |
| ADARx Pharmaceuticals, Inc.NasdaqGS: ADRX | $1.98B | $17.65 | -0.73% |
| Duality Biotherapeutics, Inc.SEHK: 9606 | $1.96B | HK$170.00 | -6.95% |
| BioCryst Pharmaceuticals, Inc.NasdaqGS: BCRX | $1.95B | $7.65 | -1.67% |
| CanSino Biologics Inc.SEHK: 6185 | $1.93B | HK$30.32 | -13.42% |
| Jinyu Bio-technology Co., Ltd.SHSE: 600201 | $1.90B | CN¥11.80 | -0.34% |
| Sarepta Therapeutics, Inc.NasdaqGS: SRPT | $1.87B | $17.73 | -2.48% |
| Immunome, Inc.NasdaqCM: IMNM | $1.87B | $16.47 | -15.75% |
| ABL Bio Inc.KOSDAQ: A298380 | $1.82B | ₩43,350.00 | -9.69% |
| Mesoblast LimitedASX: MSB | $1.80B | AU$1.99 | -0.50% |
| Mineralys Therapeutics, Inc.NasdaqGS: MLYS | $1.79B | $20.30 | -13.14% |
| Vir Biotechnology, Inc.NasdaqGS: VIR | $1.79B | $10.57 | +1.34% |
| AlvotechNasdaqGM: ALVO | $1.78B | $5.00 | -13.49% |
| Wuhan Healthgen Biotechnology Corp.SHSE: 688765 | $1.77B | CN¥33.19 | -12.33% |
| Hyperliquid Strategies Inc.NasdaqCM: PURR | $1.74B | $8.78 | +1.15% |
| Palvella Therapeutics, Inc.NasdaqGM: PVLA | $1.73B | $120.30 | -13.31% |
| Xencor, Inc.NasdaqGM: XNCR | $1.70B | $22.85 | -7.23% |
| Hualan Biological Vaccine Inc.SZSE: 301207 | $1.69B | CN¥19.03 | -0.47% |
| UroGen Pharma Ltd.NasdaqGM: URGN | $1.69B | $34.56 | -6.16% |
| Voronoi, Inc.KOSDAQ: A310210 | $1.68B | ₩123,200.00 | -10.98% |
| OliX Pharmaceuticals, IncKOSDAQ: A226950 | $1.67B | ₩98,000.00 | -16.45% |
| Nanjing Vazyme Biotech Co., LtdSHSE: 688105 | $1.64B | CN¥21.24 | -20.15% |
| Zenas BioPharma, Inc.NasdaqGS: ZBIO | $1.62B | $24.84 | -8.88% |
| Stoke Therapeutics, Inc.NasdaqGS: STOK | $1.62B | $25.04 | -2.57% |
| Novavax, Inc.NasdaqGS: NVAX | $1.60B | $9.70 | -2.90% |
| Immunocore Holdings plcNasdaqGS: IMCR | $1.60B | $30.98 | -3.55% |
| Chengdu Olymvax Biopharmaceuticals Inc.SHSE: 688319 | $1.59B | CN¥26.26 | -12.73% |
| Absci CorporationNasdaqGS: ABSI | $1.58B | $9.18 | -2.03% |
| Pell Bio-Med Technology Co., Ltd.TWSE: 6949 | $1.57B | NT$38.90 | -16.97% |
| Intellia Therapeutics, Inc.NasdaqGM: NTLA | $1.57B | $11.21 | +0.45% |
| Yantai Dongcheng Pharmaceutical Group Co.,Ltd.SZSE: 002675 | $1.56B | CN¥12.66 | -8.86% |
| uniQure N.V.NasdaqGS: QURE | $1.56B | $22.43 | -2.94% |
| COMPASS Pathways plcNasdaqGS: CMPS | $1.55B | $11.18 | -3.87% |
| Staidson (Beijing) BioPharmaceuticals Co., Ltd.SZSE: 300204 | $1.53B | CN¥18.94 | -8.33% |
| Biotest GmbH & Co. KGaAHMSE: BIO0 | $1.49B | €33.40 | +11.33% |
| Nanobiotix S.A.ENXTPA: NANO | $1.47B | €25.78 | -0.54% |
| Vitrolife AB (publ)OM: VITR | $1.45B | Skr108.80 | +5.94% |
| Hugel, Inc.KOSDAQ: A145020 | $1.45B | ₩179,100.00 | -2.02% |
| Everest Medicines LimitedSEHK: 1952 | $1.45B | HK$32.36 | +9.32% |
| Novoprotein Scientific Inc.SHSE: 688137 | $1.45B | CN¥139.41 | -13.51% |
| Mabwell (Shanghai) Bioscience Co., Ltd.SHSE: 688062 | $1.44B | CN¥22.29 | -10.05% |
| Ultragenyx Pharmaceutical Inc.NasdaqGS: RARE | $1.43B | $14.54 | -6.07% |
| L&C BIO Co.,LTDKOSDAQ: A290650 | $1.42B | ₩70,100.00 | +24.29% |
| Ascentage Pharma Group InternationalSEHK: 6855 | $1.39B | HK$29.74 | +5.39% |
| Inhibrx Biosciences, Inc.NasdaqGS: INBX | $1.37B | $93.38 | -3.89% |
| AnaptysBio, Inc.NasdaqGS: ANAB | $1.36B | $45.43 | -7.74% |
| Wedge Industrial Co.,Ltd.SZSE: 000534 | $1.36B | CN¥18.80 | -9.57% |
| Pharma Mar, S.A.BME: PHM | $1.34B | €69.25 | -2.05% |
| Idorsia LtdSWX: IDIA | $1.34B | CHF4.10 | -2.33% |
| InventisBio Co., LimitedSHSE: 688382 | $1.34B | CN¥15.44 | -10.54% |
| Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403 | $1.33B | CN¥9.50 | -4.62% |
| Shanghai OPM Biosciences Co., Ltd.SHSE: 688293 | $1.32B | CN¥62.02 | -13.26% |
| GenFleet Therapeutics (Shanghai) Inc.SEHK: 2595 | $1.31B | HK$27.86 | -2.59% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.31B | ₩38,100.00 | -11.09% |
| PYC Therapeutics LimitedASX: PYC | $1.31B | AU$1.91 | -22.04% |
| BioGaia AB (publ)OM: BIOG B | $1.30B | Skr127.30 | -1.55% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.29B | $3.96 | -1.12% |
| Seegene, Inc.KOSDAQ: A096530 | $1.29B | ₩37,750.00 | -1.05% |
| ORIC Pharmaceuticals, Inc.NasdaqGS: ORIC | $1.28B | $12.35 | +3.00% |
| Tyra Biosciences, Inc.NasdaqGS: TYRA | $1.27B | $18.52 | -7.12% |
| Freenome, Inc.NasdaqCM: FRNM | $1.26B | $11.75 | -25.54% |
| Chongqing Genrix Biopharmaceutical Co., Ltd.SHSE: 688443 | $1.26B | CN¥23.00 | -7.82% |
| Liaoning Chengda Biotechnology Co., Ltd.SHSE: 688739 | $1.25B | CN¥20.33 | -4.10% |
| GNI Group Ltd.TSE: 2160 | $1.23B | ¥2,945.00 | -7.97% |
| BeBetter Med Inc.SHSE: 688759 | $1.22B | CN¥18.19 | -9.28% |
| Nektar TherapeuticsNasdaqCM: NKTR | $1.22B | $35.78 | -13.09% |